Pharmacoeconomic impact of use of the probiotic Lactobacillus reuteri DSM 17938 for prevention of necrotizing enterocolitis in extremely low-birth-weight infants

Pharmacoeconomic impact of use of the probiotic Lactobacillus reuteri DSM 17938 for prevention of necrotizing enterocolitis in extremely low-birth-weight infants

Mary Ann VT Dimaguila,1,2 Peter Gal,1,3,4 Tiffany Wilson,1 John E Wimmer Jr,1,2 McCrae Smith,1,2 Rita Q Carlos,1,2 Christie C Davanzo,1,2 J Laurence Ransom1,2 1Women's Hospital of Greensboro, Cone Health, Greensboro, NC, USA; 2Piedmont Neonatology, Greensboro, NC, USA; 3Eshelman School of Ph...

Full description

Bibliographic Details
Main Authors: Dimaguila MAVT, Gal P, Wilson T, Wimmer Jr JE, Smith M, Carlos RQ, Davanzo CC, Ransom JL
Format: Article
Language:English
Published: Dove Medical Press 2013-04-01
Series:Research and Reports in Neonatology
Online Access:http://www.dovepress.com/pharmacoeconomic-impact-of-use-of-the-probiotic-lactobacillus-reuteri--a12638

Internet

http://www.dovepress.com/pharmacoeconomic-impact-of-use-of-the-probiotic-lactobacillus-reuteri--a12638

Similar Items